Sign in
Taking peopleNo phase

Testing a clot removal device for deep vein thrombosis in the leg

Tests a device that removes blood clots in adults with leg deep vein thrombosis.

Key facts

Who runs it
BrosMed Medical Co., Ltd
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Clinical Trial of Thrombectomy Systems
Status
Recruiting
People taking part
167 people, planned
Started
30 Aug 2026
Expected to end
30 Dec 2027
Type of study
Interventional
Treatments tested
  • Peripheral thrombectomy system
Record updated
7 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a blood clot in a deep vein of the leg (DVT), confirmed by imaging. It tests a device that removes the clot.

Age
18 years and older
Sex
All sexes can join
Disease stage
Acute clot in the iliofemoral or femoropopliteal veins, or subacute clot in the iliofemoral veins. Expected to live at least 1 year.
Earlier treatment
People whose clot came back after an earlier procedure on the same spot cannot join. People with a stent already in the target vein cannot join.

Main reasons for not taking part

  • Clots in both legs that need removal in the same procedure
  • Unstable blood clot in the lungs (pulmonary embolism)
  • Active bleeding or a stroke within the past 30 days
  • Severe bleeding or clotting disorder, or severe liver or kidney problems
  • Pregnant or breastfeeding, or planning a pregnancy during the study

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Age ≥18 years;
  • Confirmed lower extremity deep vein thrombosis (DVT) by imaging, meeting at least one of the following: (1) acute iliofemoral or femoropopliteal DVT; or (2) subacute iliofemoral DVT
  • Investigator-assessed life expectancy ≥1 year
  • Willing to participate in this study and provide written informed consent

Who cannot take part

  • The target lesion thrombosis is recurrent after prior interventional therapy
  • Currently participating in any other clinical trial of a drug or medical device
  • Infection at the puncture site or severe systemic infection
  • Bilateral lower extremity deep vein thrombosis requiring thrombectomy in the same procedure
  • Active bleeding within the past 30 days, including severe intracranial, gastrointestinal, or urinary tract bleeding
  • History of hemorrhagic or ischemic stroke within the past 30 days
  • Known severe coagulation disorder or bleeding tendency
  • Severe hepatic or renal impairment
  • Known allergy or significant hypersensitivity to iodine-based contrast media, thrombolytic agents, anticoagulants, or antiplatelet drugs
  • Known conditions such as severe hyperthyroidism, multiple myeloma, or severe heart failure that preclude tolerance to percutaneous transluminal angioplasty
  • Any other condition that, in the investigator's judgment, makes the subject ineligible for participation in this trial
  • Inability to establish vascular access or difficulty in advancing the guidewire through the lesion
  • Hemodynamically unstable pulmonary embolism
  • A venous stent has been implanted in the target lesion, or the presence of an inferior vena cava filter that interferes with device deployment
  • Pregnant or lactating women, or women planning to become pregnant during the study period

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study plans to enroll 167 subjects. Subject enrollment and treatment details will be documented, and follow-up assessments will be conducted at screening, on the procedure day, before discharge, and at 1, 3, and 6 months after the procedure, to assess the safety and efficacy of the peripheral thrombectomy system for the treatment of lower extremity deep vein thrombosis.

The group in the trial

  • Test groupTreatment being tested

    Thrombectomy system

    Treatment: Peripheral thrombectomy system

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Multicenter, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Thrombectomy Systems for the Treatment of Lower Extremity Deep Vein Thrombosis
Plain-language title
Testing a clot removal device for deep vein thrombosis in the legGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
7 August 2026